ONCOLOGY & CNS EXPERTS
WE ARE AT THE FOREFRONT OF ONCOLOGY & NEURORADIOLOGY IMAGING
Value-Driven Solutions: Empowering Your Growth and Success
Revolutionizing Imaging Solutions in Oncology and CNS Research
We specialize in providing advanced imaging solutions for oncology and CNS research. We understand the unique challenges faced by biotech companies in these fields, such as complex imaging modalities and the need for seamless integration.
With our expertise, we offer optimized imaging protocols, comprehensive image analysis, and robust project management support. Experience the transformative power of our tailored imaging solutions, accelerating research and delivering meaningful results in oncology and CNS studies.
Why Work with Us
Biometric Evaluations
- Prediction of immune response
- ER/PR, proliferation
- Early detection
- EMT
- Prognostic signatures in solid tumors
- Pseudo-progression
- Hallmarks of cancer
Functional Evaluations
- Perfusion measurements (PET, DCE-MRI and CT)
- Metabolic and proliferation (PET/CT – FDG, 11C-methionine & FLT, 18F-Axumin,18F-FES, 68Ga-PSMA-11, 68Ga-DOTA)
Semi-Quantitative Evaluations
- RECIST (1.0, 1.1), mRECIST
- iRECIST, itRECIST, irRECIST, irRC
- WHO criteria
- PERCIST and EORTC criteria for PET response
- CHOI criteria for response to tumors
- Macdonald, RANO, iRANO, mRANO and RAPNO for Neuro-Oncology
- PCWG3 criteria for Prostate cancer
- Cheson, Lugano and RECIL for lymphoma;
- Olsen criteria
- IWCLL for CLL
- MDA for bone metastases
- Pseudo progression measurements
Quantitative Evaluations
- Tumor volume – based on CT, MRI
- Tumor metabolic volume and Tumor lesion glycolysis (PET/CT)
- Tumor density
- Tumor kinetics
- Tumor heterogeneity with QTA
- Bone metastasis burden on Bone Scans
Comprehensive Modalities
- PET/CT and SPECT/CT – multiple radiopharmaceuticals
- MRI – DCE, ADC, anatomical, spectroscopy
- CT – Perfusion, anatomical
- Breast-based imaging modalities: MRI, digital mammography,
- ultrasound, tomosynthesis
- US
- Angiography
- X-ray, Planar Nuclear Medicine (Bone Scans, etc)
Immune Therapy and Immune System Imaging
- Cellular therapy with overactive trials in hematology and solid tumors
- Viral therapy in neuro-oncology and systemic disease
- Intra-tumoral injections and vaccines
- CPI therapy
- Rational combinations include ablative therapy, radiation therapy and novel immune system stimulators
- PET/SPECT immune imaging agents and radiomic signatures
- Immune-mediated inflammatory disease